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Background: Tuberculous meningitis (TBM) is a common central nervous system infection in the Philippines;
however it is difficult to diagnose as findings are non-specific. Hence we decided to determine if, among patients
with chronic meningitis syndrome, the following are associated with the diagnosis: new-onset seizures; focal
neurologic deficit; pulmonary tuberculosis (PTB) on chest X-ray; cerebrospinal fluid (CSF) pleocytosis with
lymphocytic predominance; decreased CSF glucose; increased CSF protein.
Methods: Adult patients with suspected TBM were enrolled after informed consent was obtained. Baseline physical
examination and diagnostic tests including CT scan of the head with contrast and CSF analysis for acid fast bacilli
(AFB) smear, TB culture and cryptococcal antigen detection were done and results collected. Definite TBM was
defined as positive AFB smear or positive TB culture or positive basal meningeal enhancement on CT contrast
study. Logistic regression was done to determine which were associated with a diagnosis of TBM.
Results: 91 patients were included. Using the gold standard criteria mentioned above, 44 had definite TBM; but if
subsequent clinical course and response to anti-Koch’s therapy are considered, 68 had a final diagnosis of TBM.
After logistic regression was performed, only abnormal CSF (the combination of CSF pleocytosis with lymphocytic
predominance, decreased CSF glucose, and increased CSF protein) was associated with the diagnosis of TBM.
Conclusion: In patients with chronic meningitis syndrome, only abnormal CSF was associated with the diagnosis
of TBM.
Background
Tuberculous meningitis (TBM) is the most dreaded
manifestation of tuberculosis, and is a common infection
of the central nervous system (CNS) especially in devel-
oping countries like the Philippines where tuberculosis
is highly endemic. The incidence follows that of pul-
monary tuberculosis, and is associated with high mortal-
ity and morbidity [1]. In a large-scale epidemiological
s t u d yo fe x t r a p u l m o n a r yt uberculosis in the United
States, CNS involvement was noted in 5-10% of extra-
pulmonary tuberculosis cases, with more recent CDC
data in 2005 indicating that 6.3% of extrapulmonary
cases (1·3% of total tuberculosis cases) involve the CNS
[2].
Tuberculosis in the Philippines ranks sixth among the
top causes of morbidity and mortality, with rates of
134·1/100,000 and 31·2/100,000 respectively in 2005. As
for TB of the CNS, based on partial prevalence data
from eight Metro Manila hospitals, TBM is the most
common primary CNS infection in adults in the coun-
try, accounting for 28·9% of all cases of primary CNS
infections [3]. In the Philippine General Hospital the
case fatality rate for CNS infections is 20%, and prog-
nosis depends on how soon a diagnosis is made and
appropriate therapy is started.
The diagnosis of TBM remains to be difficult. As with
other forms of TB the gold standard is isolation of the
organism through culture or detection of its presence by
acid-fast staining. However the yield from acid-fast
staining and culture remains to be very low, probably
because of the low concentration of bacilli in the cere-
brospinal fluid (CSF). The author’so w ns e r i e so f6 3
cases had a positive culture yield in only 3 of these [4].
Molecular methods, such as polymerase chain reaction
(PCR)-based diagnostic techniques, have begun to be
applied in the local setting, but are relatively expensive,
and the yield greatly depends on stringent quality
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dence of TBM, such as the changes in the cerebrospinal
fluid, as well as the absence of another likelier diagnosis.
Hence the search continues for a reliable, accurate, yet
easily performed and inexpensive diagnostic test.
Due to the unsatisfactory nature of current diagnostic
methods, some have formulated clinical decision rules to
determine the likelihood of a diagnosis of TBM using only
clinical and simple laboratory findings. Thwaites et al. [1]
compared the clinical and laboratory features of 251 Viet-
namese adults with either tuberculous or bacterial menin-
gitis. Five features were independently associated with a
diagnosis of tuberculous meningitis: age, length of history,
white blood cell count, total cerebrospinal fluid (CSF)
white cell count, and CSF neutrophil proportion. However
this study included patients with bacterial meningitis,
which is often not an important differential diagnosis in
patients with TBM. More recently, Moghtaderi et al. [5]
retrospectively compared clinical and laboratory features
in 68 Iranian patients with TBM and 123 cases of acute
bacterial meningitis. Disease duration of ≤ 5d a y s ,a g eo v e r
30 years, CSF leukocytosis and lymphocytosis were inde-
pendent predictive factors for a diagnosis of TBM.
The common limitation of these researches is that not
enough patients with a chronic meningitis syndrome
were included in their patient populations. Patients with
TBM were usually compared to patients with acute bac-
terial meningitis, when clinically this problem is not
often encountered. It is frequently more crucial to dif-
ferentiate between the different causes of a chronic
meningitis syndrome, such as cryptococcal meningitis.
Tests to rule out this important differential diagnosis
were apparently not carried out in the above studies
mentioned. These shortcomings are addressed in the
present study.
While the ideal diagnostic test is still to be developed,
clinicians need to know which features are associated
with the diagnosis of TBM, so that appropriate therapy
can be started early, and the toxicities of unnecessary
treatment can be avoided, hence improving the likeli-
hood of a good outcome for patients with this devastat-
ing illness. The results of this study will hopefully
contribute to determining which clinical and simple
laboratory features are associated with the diagnosis in
the local setting.
This study aimed to determine if the following clinical
and laboratory features are associated with a diagnosis
of definite TBM in patients with chronic meningitis syn-
drome: new-onset seizures; focal neurologic deficit; (+)
PTB on chest X-ray; CSF lymphocytic pleocytosis (pre-
dominance of lymphocytes rather than neutrophils,
which is more characteristic of a chronic infection such
as TBM, as in Figure 1); decreased CSF glucose;
increased CSF protein.
Methods
This is a prospective cross-sectional validity study car-
ried out at the Philippine General Hospital. The opera-
tional definitions adopted for this study are as follows:
a. Definite Tuberculous meningitis (TBM): Any
patient whose cerebrospinal fluid (CSF) is positive
for AFB smear or positive for TB culture or with
basal meningeal enhancement on CT head contrast
study (Figure 2).
b. Chronic meningitis syndrome: any patient with
7d a y so rm o r eh i s t o r yo fa n y2o ft h ef o l l o w i n g :
headache (as subjectively reported by the patient or
family member); fever (any subjective report of
increased body temperature); sensorial change.
Figure 1 CSF pleocytosis with lymphocytic predominance in
abnormal CSF smears.
Figure 2 CT scan of head showing basal meningeal
enhancement on contrast study. Arrow points to a tuberculoma.
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ium from normal awake to decrease (drowsiness/stu-
por/coma) or increase (delirium/restlessness).
d. New-onset seizure: development of any type of
seizure since the start of the patient’s present illness.
e. Focal neurologic deficit: development of any of
the following since the start of the patient’sp r e s e n t
illness: dysphasia, dyspraxia, agnosia, dyscalculia,
left-right disorientation, cranial nerve deficit such as
anosmia, dysarthria, weakness of one or more limbs,
sensory deficit in one or more limbs, dysmetria,
ataxia.
f. Pulmonary TB: chest X-ray interpreted as pul-
monary TB by a radiologist.
g. Basal meningeal enhancement on CT head
contrast study: marked contrast enhancement out-
lining the basal cisterns on head CT, as interpreted
by a radiologist.
h. CSF pleocytosis with lymphocytic predomi-
nance: presence of more than 50 white cells/mm
3
on microscopic examination of the CSF, with more
lymphocytes than polymorphonuclear cells (Figure
1).
i. Decreased CSF glucose: value of CSF glucose
50% or less than simultaneous serum glucose
determination.
j. Increased CSF protein: value of CSF protein
more than the upper limit of normal of the perform-
ing laboratory’s reference values, i.e. > 0.45 mg/dl.
k. Abnormal CSF: presence of all 3 of the above
CSF findings (CSF pleocytosis with lymphocytic pre-
dominance + decreased CSF glucose + increased
CSF protein.
Prior to carrying out this study, ethical approval was
obtained from the Research Implementation and Devel-
opment Office of the University of the Philippines Col-
lege of Medicine.
Any adult patient with any two of headache, fever, or
sensorial change, of at least 7 days duration, and without
any other apparent etiology of the illness, was consid-
ered to have chronic meningitis syndrome and included
in the study after appropriate informed consent was
obtained. The following baseline diagnostic tests were
performed on all enrolled patients: cranial CT scan with
and without contrast; chest X-ray; and lumbar puncture
for CSF analysis. Aliquots of the CSF obtained were sent
for the following examinations: 2-3 cc for AFB smear
and TB culture (Bactec method), 2-3 cc for routine bac-
teriologic Gram stain & culture, and 1-2 cc for India ink
stain & cryptococcal latex agglutination test (CALAS).
Patients were treated according to the results of the
above examinations, and the best clinical judgment of
the attending physician. Data on the clinical outcome
and final etiologic diagnosis upon discharge were
collected.
All data were entered using Excel software in an Excel
file. Descriptive statistics for demographic variables were
calculated; crude odds ratios for the presence of each of
the above clinical features were then obtained, and logis-
tic regression was performed.
Results
A total of 91 adult patients with chronic meningitis syn-
d r o m ew e r ee n r o l l e di nt h es t u d yf r o mJ u l y2 0 0 5t o
June 2008, with an age range of 19-76 years old (mean
35·3 years old, s. d. 14·0) and male: female ratio of
1·53:1. Of these 91 patients, 44 were diagnosed to have
definite TBM according to the composite reference
standard (positive for AFB smear or positive for TB cul-
ture or with basal meningeal enhancement on CT head
examination, as in Figure 2).
If subsequent clinical course, follow-up data, results of
other laboratory examinations, and response to anti-
Koch’s therapy are taken into account, 68 had a final
diagnosis of TBM upon discharge based on the attend-
ing physician’s clinical assessment, while 22 had other
alternative diagnoses (Table 1).
To find out which clinical and laboratory features
were associated with a diagnosis of TBM, we performed
univariate analysis of the data using simple logistic
regression (Table 2). Taken individually, lymphocytic
pleocytosis, decreased glucose, or increased protein,
would seem to be significant predictive factors of a diag-
nosis of TBM.
After logistic regression, however, these 3 factors were
no longer significant. But since these 3 CSF features
were initially significant on univariate analysis, and in
clinical practice they are usually considered together, we
decided to combine them to determine if this new vari-
able would be significant after multiple regressions.
Accordingly, the new variable was named “abnormal
Table 1 Final diagnosis in 91 study patients
Final Diagnosis Frequency (%)
TB meningitis 68 (74·7)
Bacterial meningitis 6 (6·6)
Viral encephalitis 6 (6·6)
Septic encephalopathy 3 (3·3)
Cryptococcal meningitis 2 (2·2)
Metabolic Encephalopathy 2 (2·2)
Hypoxia 1 (1·1)
Normal pressure hydrocephalus 1 (1·1)
Subarachnoid hemorrhage 1 (1·1)
No final diagnosis 1 (1·1)
Grand Total 91 (100%)
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if the patient had all 3 CSF features (lymphocytic pleo-
cytosis, decreased glucose, increased protein).
Univariate analysis was then repeated for all the four
features (abnormal CSF, new-onset seizure, new-onset
deficit, and (+) PTB on CXR.) The results are shown in
Table 3. The new variable, abnormal CSF is now the
only factor which turns out to be significant after uni-
variate analysis.
After logistic regression analysis, abnormal CSF
remained significant (Table 4). For this overall logistic
regression model, the likelihood ratio statistic is 8·80,
with a p-value of 0·06. Given this result of near signifi-
cance at an alpha level of 0·05, it would be helpful to
proceed in assessing the effect of the predictor variables
when taken together in the diagnosis of TBM.
In order to further assess the significance of abnormal
CSF as well as the other factors, the likelihood ratio test
was performed to identify factors associated with the
diagnosis of TBM. At the end of the LR test only abnor-
mal CSF was found to be a significant associated factor
for the diagnosis of TBM. Since only one factor was sig-
nificant, an ROC curve was no longer constructed;
instead the validity parameters of abnormal CSF as a
diagnostic test for definite TBM were calculated. The
results, shown in Table 5, reveal only a moderate sensi-
tivity and specificity, and likelihood ratios:
Discussion
In this study, clinical and widely available laboratory fea-
tures were collected from 91 patients with a chronic
meningitis syndrome to find out which of these were
associated with a diagnosis of TBM. Based on these test
results (positive for TB culture or AFB smear or basal
meningeal enhancement on contrast CT scan of the
head), only 44 would fulfil the criteria of definite TBM.
If only growth on TB culture or positive AFB smear
were used as the gold standard, then this number would
be even lower (4/91). The final discharge diagnosis was
TBM in 68 of the 91 cases, whereas there were other
alternative diagnoses in the other cases. Other CNS
infections were among the next most common final
diagnoses: bacterial and viral meningitis (6·6% each) and
cryptococcal meningitis (2·2%). Non-infectious causes
(6/91) were also among the differential diagnoses, such
as metabolic encephalopathy, hypoxia, and subarachnoid
hemorrhage, but these are usually easily ruled out on
the basis of history, PE, and simple laboratory
examinations.
Due to the low yield of conventional TB culture or
AFB smear in our setting, we chose to include basal
meningeal enhancement on CT contrast study of the
head as part of the gold standard criteria for TBM. Sev-
eral authors have determined the validity of this
approach: Kumar (1996) compared the CT findings of
94 children with TBM with those of 52 children with
pyogenic meningitis, and concluded that basal menin-
geal enhancement, tuberculoma, or both, were 89% sen-
sitive and 100% specific for the diagnosis of TBM.
Przybojewski [5] showed that the criteria most clinically
useful were the Y-sign, linear enhancement, contrast fill-
ing the cisterns, and asymmetry, due to their high likeli-
hood ratios.
Due to the shortcomings of the laboratory examina-
t i o n su s e da st h eg o l do rr e f e r e n c es t a n d a r di nt h i s
study, an alternate reference standard could have been
Table 2 Univariate analysis of potential factors associated with a diagnosis of definite TBM; definite TBM = 44; not
definite TBM = 47
Factor (+) in definite TBM
(n = 44)
(-) in definite TBM
(n = 44)
Crude odds ratio 95% C. I. P value
New-onset seizure 14 13 1·04 0·38-2·86 0·93
New-onset neurologic deficit 24 21 0·45 1·19-2·93 0·76
Presence of PTB 15 10 1·72 0·60-4·98 0·26
Lymphocytic pleocytosis 32 18 3·56 1·32-9·74 0·005
Decreased glucose 33 21 3·00 1·10-8·30 0·017
Increased protein 40 30 4·89 1·12-24·43 0·015
Table 3 Univariate analysis of potential factors associated with definite TBM; definite TBM = 44; not definite TBM = 47
Factor (+) in definite TBM
(n = 44)
(-) in definite TBM
(n = 44)
Crude odds ratio 95% C. I. P value
New-onset seizure 14 13 1·04 0·38-2·86 0·93
New-onset neurologic deficit 24 21 1·14 0·45-2·93 0·76
Presence of PTB 15 10 1·72 0·60-4·98 0·26
Abnormal CSF 26 13 3·78 1·44-10·04 0·002
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least two experts would examine each chart and arrive
at a consensus as to whether each patient did indeed
have TBM. Important data such as the response to anti-
Koch’s medications could have been taken into account
for the panel to arrive at a diagnostic decision with a
confident level of certainty. However the panel would
have to be blinded to the results of the tests being stu-
died as possible predictive factors, lest incorporation
bias come about and artificially inflate the odds ratios.
It is unfortunate that only abnormal CSF was found to
be associated with the diagnosis of TBM, in contrast to
previous studies. Thwaites, Kumar, Sunbul, Youssef, and
Moghtaderi [1,6-9], cited in the review of literature.
This may be because of differences in the study popula-
tion. In the earlier studies, the population was of
patients presenting as a meningitis syndrome, whether
acute or chronic; cases of TBM were compared with
other bacterial meningitides, but arguably this would
not be useful in an actual clinical setting because it is
not often that clinicians have to discriminate between
TBM and acute bacterial meningitis. More often the
dilemma is to distinguish between TBM and other
c h r o n i cm e n i n g i t i d e ss u c ha sc r y p t o c o c c a lm e n i n g i t i s .
Also, the population in the present study would be
more relevant for local clinicians, as the clinical presen-
tation of TBM in the country may be different from
places such as Vietnam and India, places with high HIV
prevalence, where the previous studies were carried out.
Coinfection with HIV increases the risk of TBM and
modifies the clinical presentation: usually patients would
present with acellular CSF and high AFB loads [6].
This study shows that diagnostic rules and prediction
models which were developed in one setting may not
necessarily be relevant in another setting, as the factors
which were found relevant in previous studies turned
out not to be significant in the local setting, most prob-
ably due to differences in the study population.
This study also shows that an abnormal CSF profile
(lymphocytic pleocytosis + decreased glucose +
increased protein) has a moderate sensitivity and specifi-
city, in fact comparable with more advanced molecular
methods such as PCR, and a definite improvement over
the current gold standard of AFB smear or TB culture.
Hence in the setting of a chronic meningitis syndrome,
clinicians confronted with this finding may be reason-
ably confident of the diagnosis of TBM, and use the
associated likelihood ratios to arrive at a decision as to
whether to order more tests or proceed with anti-Koch’s
treatment. Also, clinicians confronted with these find-
ings should first rule out those conditions which have
entirely different therapies, such as cryptococcal menin-
gitis and partially-treated bacterial meningitis, by doing
the appropriate laboratory exams. In those patients
where it is not immediately evident what the etiologic
organism is, then the best course would be to treat for
TBM and start anti-Koch’s medications by default, as
this is the most prevalent etiology of a chronic meningi-
tis in the local setting, and then to also institute addi-
tional treatment for those other conditions which the
clinician is ruling in. He may then modify his subse-
quent management based on the response to therapy,
and a repeat of the pertinent laboratory exams where
appropriate.
There are some limitations to this study:
1) The desired sample size was not achieved within
the time frame of this study; conceivably some factors
would turn out to be positively predictive if a larger
population were studied;
2) There is subjectivity involved in assessing for the
presence of basal meningeal enhancement on CT head
contrast study; also inter-rater and intra-rater variability
was not assessed. This would have affected the perfor-
mance of the gold standard test.
3) Related to this, the yield of the conventional gold
standard tests, which are AFB smear and TB culture, is
still very low. If these were the only tests considered as
part of the composite gold standard, then it would have
been useless to proceed with the logistic regression.
Some techniques that may be used to improve the yield
of AFB staining include staining the clot that forms in
standing CSF and spinning down the CSF sediment
onto a slide for microscopic examination. In 1979, Ken-
nedy and Fallon [10] showed that staining multiple sam-
ples of CSF enhanced the sensitivity to 86%.
4) Finally, the presence of HIV co-infection was not
tested. As mentioned earlier, a high rate of co-infection
with HIV may affect the clinical presentation and affect
the choice of clinical and laboratory features to be
studied.
Table 4 Overall Logistic Regression of possible predictive
factors of TBM
Factor Odds ratio 95% C. I. P value
New-onset seizure 1·49 0·54-4·07 0·44
New-onset neurologic deficit 1·17 0·47-2·90 0·72
Presence of PTB 2·06 0·74-5·72 0·17
Abnormal CSF 3·27 1·30-8·22 0·01
Table 5 Validity parameters of abnormal CSF for the
diagnosis of TBM
Parameter Value 95% C. I.
Sensitivity 0·57 0·42-0·71
Specificity 0·69 0·55-0·81
Likelihood ratio (+) 1·89 1·12-3·20
Likelihood ratio (-) 0·61 0·41-0·91
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Thus we conclude that only abnormal CSF (lymphocytic
pleocytosis + decreased glucose + increased protein) is
associated with a diagnosis of TBM in patients with a
chronic meningitis syndrome.
We recommend that these results be validated in a
larger sample of patients with chronic meningitis; also
that the current gold standard be improved. The yield
of AFB smear and culture should be improved by
proper training of medical technologists to do more
meticulous examination of a larger sample, while new
and more sensitive methods for TB culture can be
developed.
A tt h es a m et i m em o r ed e f i n i t ea n do b j e c t i v ec r i t e r i a
for basal meningeal enhancement on contrast CT scan
of the head should be developed, while consistency and
inter- and intra-rater variability among readers should
be checked.
Lastly HIV co-infection should be checked, now that
t h ep r e v a l e n c eo fH I Vi nt h ec o u n t r yi sr e p o r t e dt ob e
increasing and may perhaps affect the clinical presenta-
tion and prevalence of TBM. While a definitive diagnos-
tic laboratory exam is not yet a reality, we believe that a
consensus definition of TBM should be formulated by
clinicians and experts, and this will ultimately be most
useful in coming up with a definition of TBM that will
be relevant for subsequent researchers and clinicians.
The finding of abnormal CSF can greatly aid clinicians
and researchers who will opt to use a consensus panel
method for determining whether a particular patient has
TBM, and greatly aid subsequent management.
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